NASDAQ:BABY - Natus Medical Stock Price, Price Target & More

$36.45 +0.55 (+1.53 %)
(As of 04/19/2018 09:12 AM ET)
Previous Close$35.90
Today's Range$35.78 - $36.79
52-Week Range$28.00 - $43.60
Volume259,661 shs
Average Volume525,077 shs
Market Capitalization$1.19 billion
P/E Ratio25.14
Dividend YieldN/A
Beta0.47

About Natus Medical (NASDAQ:BABY)

Natus Medical logoNatus Medical Incorporated is a provider of newborn care and neurology healthcare products and services used for the screening, diagnosis, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, neuromuscular diseases and balance and mobility disorders. The Company's product offerings include computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology, as well as newborn care products, such as hearing screening systems, phototherapy devices for the treatment of newborn jaundice, head-cooling products for the treatment of brain injury in newborns, incubators to control the newborn's environment, and software systems for managing and tracking disorders and diseases for public health laboratories. The Company is organized into three strategic business units: Neurology, Newborn Care and Otometrics.

Receive BABY News and Ratings via Email

Sign-up to receive the latest news and ratings for BABY and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Electromedical equipment
Sub-IndustryHealth Care Equipment
SectorMedical
SymbolNASDAQ:BABY
CUSIP63905010
Phone925-223-6700

Debt

Debt-to-Equity Ratio0.37%
Current Ratio3.32%
Quick Ratio2.54%

Price-To-Earnings

Trailing P/E Ratio25.14
Forward P/E Ratio22.36
P/E GrowthN/A

Sales & Book Value

Annual Sales$500.97 million
Price / Sales2.41
Cash Flow$2.5490 per share
Price / Cash14.30
Book Value$13.55 per share
Price / Book2.69

Profitability

EPS (Most Recent Fiscal Year)$1.45
Net Income$-20,290,000.00
Net Margins-4.05%
Return on Equity11.36%
Return on Assets6.96%

Miscellaneous

Employees1,726
Outstanding Shares33,160,000

How to Become a New Pot Stock Millionaire

Natus Medical (NASDAQ:BABY) Frequently Asked Questions

What is Natus Medical's stock symbol?

Natus Medical trades on the NASDAQ under the ticker symbol "BABY."

How will Natus Medical's stock buyback program work?

Natus Medical declared that its board has approved a share buyback program on Thursday, February 22nd 2018, which permits the company to repurchase $30,000,000.00 in shares, according to EventVestor. This repurchase authorization permits the company to repurchase shares of its stock through open market purchases. Stock repurchase programs are typically a sign that the company's board believes its shares are undervalued.

How were Natus Medical's earnings last quarter?

Natus Medical Inc (NASDAQ:BABY) issued its quarterly earnings data on Wednesday, February, 7th. The medical equipment provider reported $0.42 EPS for the quarter, missing analysts' consensus estimates of $0.54 by $0.12. The medical equipment provider earned $131.40 million during the quarter, compared to analyst estimates of $131.38 million. Natus Medical had a positive return on equity of 11.36% and a negative net margin of 4.05%. Natus Medical's revenue was up 22.0% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.51 EPS. View Natus Medical's Earnings History.

When is Natus Medical's next earnings date?

Natus Medical is scheduled to release their next quarterly earnings announcement on Wednesday, April, 25th 2018. View Earnings Estimates for Natus Medical.

What guidance has Natus Medical issued on next quarter's earnings?

Natus Medical issued an update on its first quarter earnings guidance on Wednesday, February, 7th. The company provided EPS guidance of $0.23-0.24 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.24. The company issued revenue guidance of $125-127 million, compared to the consensus revenue estimate of $123.91 million.

What price target have analysts set for BABY?

3 analysts have issued twelve-month target prices for Natus Medical's stock. Their predictions range from $39.00 to $49.00. On average, they anticipate Natus Medical's share price to reach $44.00 in the next year. View Analyst Ratings for Natus Medical.

Who are some of Natus Medical's key competitors?

Who are Natus Medical's key executives?

Natus Medical's management team includes the folowing people:
  • Robert A. Gunst, Independent Chairman of the Board (Age 67)
  • James B. Hawkins, President, Chief Executive Officer, Director (Age 61)
  • Jonathan A. Kennedy, Chief Financial Officer, Executive Vice President, IR Contact Officer (Age 46)
  • Leslie McDonnell, Vice President and General Manager - Newborn Care Business Unit
  • Austin F. Noll III, Vice President and General Manager - Neurology Strategic Business Unit (Age 50)
  • D. Christopher Chung M.D., Vice President - Medical Affairs, Quality & Regulatory (Age 53)
  • Doris E. Engibous, Independent Director (Age 62)
  • Kenneth E. Ludlum, Independent Director (Age 62)
  • William M. Moore Jr., Independent Director (Age 66)
  • Barbara R. Paul M.D., Independent Director (Age 63)

Has Natus Medical been receiving favorable news coverage?

Media stories about BABY stock have trended positive this week, Accern reports. The research group identifies positive and negative media coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Natus Medical earned a coverage optimism score of 0.30 on Accern's scale. They also gave press coverage about the medical equipment provider an impact score of 44.14 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company's share price in the next several days.

How do I buy shares of Natus Medical?

Shares of BABY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Natus Medical's stock price today?

One share of BABY stock can currently be purchased for approximately $36.45.

How big of a company is Natus Medical?

Natus Medical has a market capitalization of $1.19 billion and generates $500.97 million in revenue each year. The medical equipment provider earns $-20,290,000.00 in net income (profit) each year or $1.45 on an earnings per share basis. Natus Medical employs 1,726 workers across the globe.

How can I contact Natus Medical?

Natus Medical's mailing address is 6701 KOLL CENTER PARKWAY SUITE 120, PLEASANTON CA, 94566. The medical equipment provider can be reached via phone at 925-223-6700 or via email at [email protected]


MarketBeat Community Rating for Natus Medical (BABY)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  179 (Vote Outperform)
Underperform Votes:  169 (Vote Underperform)
Total Votes:  348
MarketBeat's community ratings are surveys of what our community members think about Natus Medical and other stocks. Vote "Outperform" if you believe BABY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BABY will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Natus Medical (NASDAQ:BABY) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
3 Wall Street analysts have issued ratings and price targets for Natus Medical in the last 12 months. Their average twelve-month price target is $44.00, suggesting that the stock has a possible upside of 20.71%. The high price target for BABY is $49.00 and the low price target for BABY is $39.00. There are currently 1 hold rating and 2 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyHoldHold
Consensus Rating Score: 2.672.672.252.00
Ratings Breakdown: 0 Sell Rating(s)
1 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
2 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $44.00$44.00$49.00$48.00
Price Target Upside: 20.71% upside40.35% upside69.26% upside37.14% upside

Natus Medical (NASDAQ:BABY) Consensus Price Target History

Price Target History for Natus Medical (NASDAQ:BABY)

Natus Medical (NASDAQ:BABY) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/27/2018Roth CapitalSet Price TargetBuy -> Buy$39.00MediumView Rating Details
1/16/2018BenchmarkReiterated RatingBuy -> Buy$55.00 -> $49.00LowView Rating Details
1/8/2018William BlairDowngradeOutperform -> Market PerformHighView Rating Details
2/2/2017Raymond JamesDowngradeOutperform -> Market PerformN/AView Rating Details
2/2/2017UBSDowngradeOutperform -> Market PerformN/AView Rating Details
12/16/2016Off Wall StreetInitiated CoverageSellN/AView Rating Details
(Data available from 4/19/2016 forward)

Earnings

Natus Medical (NASDAQ:BABY) Earnings History and Estimates Chart

Earnings by Quarter for Natus Medical (NASDAQ:BABY)

Natus Medical (NASDAQ:BABY) Earnings Estimates

2018 EPS Consensus Estimate: $2.09
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20181$0.38$0.38$0.38
Q2 20181$0.49$0.49$0.49
Q3 20181$0.51$0.51$0.51
Q4 20181$0.71$0.71$0.71

Natus Medical (NASDAQ BABY) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
4/25/2018$0.28N/AView Earnings Details
2/7/2018Q4 2017$0.54$0.42$131.38 million$131.40 millionViewListenView Earnings Details
10/25/2017Q3 2017$0.38$0.40$122.41 million$122.60 millionViewN/AView Earnings Details
7/26/2017Q2 2017$0.33$0.34$121.99 million$122.20 millionViewN/AView Earnings Details
4/26/2017Q1 2017$0.33$0.30$122.45 million$124.70 millionViewN/AView Earnings Details
2/1/2017Q416$0.53$0.51$107.58 million$107.70 millionViewListenView Earnings Details
10/19/2016Q316$0.34$0.39$89.94 million$90.90 millionViewListenView Earnings Details
7/20/2016Q216$0.36$0.39$92.71 million$96.00 millionViewListenView Earnings Details
4/20/2016Q116$0.30$0.34$90.47 million$87.30 millionViewListenView Earnings Details
1/27/2016Q415$0.46$0.51$100.88 million$100.00 millionViewListenView Earnings Details
10/21/2015Q315$0.38$0.39$93.70 million$94.60 millionViewListenView Earnings Details
7/22/2015Q215$0.32$0.34$90.83 million$91.90 millionViewListenView Earnings Details
4/22/2015Q115$0.29$0.31$88.93 million$89.40 millionViewListenView Earnings Details
1/28/2015Q414$0.38$0.40$93.28 million$94.00 millionViewListenView Earnings Details
10/22/2014Q314$0.31$0.33$87.30 million$89.90 millionViewListenView Earnings Details
7/23/2014Q214$0.26$0.28$84.85 million$86.30 millionViewListenView Earnings Details
4/23/2014Q114$0.23$0.26$84.70 million$85.60 millionViewListenView Earnings Details
1/29/2014Q413$0.32$0.37$89.12 million$90.60 millionViewListenView Earnings Details
10/24/2013Q313$0.19$0.30$80.83 million$85.40 millionViewListenView Earnings Details
8/1/2013Q2 2013$0.14$0.21$83.50 million$82.30 millionViewListenView Earnings Details
5/20/2013Q1 2013$0.11$0.15$84.47 million$85.80 millionViewListenView Earnings Details
2/28/2013Q4 2012$0.26$0.29$93.60 million$90.50 millionViewListenView Earnings Details
11/7/2012$0.14$0.15$81.37 million$80.70 millionViewN/AView Earnings Details
7/26/2012$0.11$0.12ViewN/AView Earnings Details
4/26/2012$0.05$0.07ViewN/AView Earnings Details
2/28/2012$0.12$0.14ViewN/AView Earnings Details
10/27/2011$0.06$0.07ViewN/AView Earnings Details
7/28/2011$0.18$0.13ViewN/AView Earnings Details
4/28/2011$0.11$0.13ViewN/AView Earnings Details
3/1/2011Q4 2010$0.22$0.24ViewN/AView Earnings Details
10/28/2010Q3 2010$0.19$0.17ViewN/AView Earnings Details
7/29/2010Q2 2010$0.14$0.15ViewN/AView Earnings Details
4/29/2010Q1 2010$0.03$0.09ViewN/AView Earnings Details
3/4/2010Q4 2009$0.15$0.15ViewN/AView Earnings Details
11/2/2009Q3 2009$0.11$0.14ViewN/AView Earnings Details
7/30/2009Q2 2009$0.05$0.08ViewN/AView Earnings Details
4/30/2009Q1 2009$0.03$0.03ViewN/AView Earnings Details
2/26/2009Q4 2008$0.21$0.22ViewN/AView Earnings Details
10/30/2008Q3 2008$0.18$0.17ViewN/AView Earnings Details
7/31/2008Q2 2008$0.14$0.15ViewN/AView Earnings Details
5/1/2008Q1 2008$0.10$0.11ViewN/AView Earnings Details
2/26/2008Q4 2007$0.18$0.17ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Natus Medical (NASDAQ:BABY) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Natus Medical (NASDAQ BABY) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 5.50%
Institutional Ownership Percentage: 95.83%
Insider Trading History for Natus Medical (NASDAQ:BABY)
Institutional Ownership by Quarter for Natus Medical (NASDAQ:BABY)

Natus Medical (NASDAQ BABY) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/2/2018Ken LudlumDirectorSell4,000$31.68$126,720.0093,825View SEC Filing  
11/13/2017William M MooreDirectorSell5,000$41.01$205,050.00View SEC Filing  
11/6/2017Dong Chune Christopher ChungVPSell12,642$42.91$542,468.22141,414View SEC Filing  
9/14/2017Robert A GunstDirectorSell4,400$35.17$154,748.0050,850View SEC Filing  
8/14/2017William M MooreDirectorSell3,000$34.10$102,300.0030,410View SEC Filing  
6/15/2017James B HawkinsInsiderBuy4,000$33.98$135,920.00578,023View SEC Filing  
5/31/2017James B. HawkinsInsiderBuy6,000$33.81$202,860.00View SEC Filing  
5/25/2017Doris EngibousDirectorSell5,000$32.68$163,400.0022,650View SEC Filing  
2/9/2017Robert A GunstDirectorSell5,000$36.00$180,000.0056,150View SEC Filing  
12/16/2016James B HawkinsInsiderBuy10,000$35.20$352,000.00477,396View SEC Filing  
10/27/2016James B HawkinsInsiderBuy10,000$38.30$383,000.00469,725View SEC Filing  
10/25/2016Jonathan KennedyCFOSell30,276$41.40$1,253,426.4091,351View SEC Filing  
10/24/2016Jonathan KennedyCFOSell14,138$41.61$588,282.1891,351View SEC Filing  
10/24/2016Robert A GunstDirectorSell3,250$41.92$136,240.0051,150View SEC Filing  
9/28/2016James B HawkinsInsiderBuy10,000$38.48$384,800.00459,725View SEC Filing  
4/26/2016Robert A GunstDirectorSell5,000$34.61$173,050.0055,000View SEC Filing  
4/22/2016Doris EngibousDirectorSell5,000$32.68$163,400.0018,250View SEC Filing  
4/22/2016Kenneth M TraversoVPSell7,459$33.56$250,324.04112,119View SEC Filing  
2/17/2016Ken LudlumDirectorSell6,625$33.02$218,757.5080,325View SEC Filing  
12/9/2015Dong Chune Christopher ChungVPSell14,000$48.78$682,920.00123,043View SEC Filing  
11/27/2015James B. HawkinsCEOSell57,511$49.09$2,823,214.99377,274View SEC Filing  
11/25/2015Austin Francis Noll IIIVPSell38,875$48.40$1,881,550.0057,934View SEC Filing  
11/12/2015James B. HawkinsCEOSell42,489$47.62$2,023,326.18434,785View SEC Filing  
10/30/2015James B. HawkinsCEOSell100,000$45.75$4,575,000.00477,274View SEC Filing  
10/28/2015Dong Chune Christopher ChungVPSell26,000$45.73$1,188,980.00123,043View SEC Filing  
10/28/2015Jonathan KennedyCFOSell28,958$45.72$1,323,959.7674,000View SEC Filing  
9/15/2015William M MooreDirectorSell5,994$40.76$244,315.4421,910View SEC Filing  
9/14/2015William M MooreDirectorSell4,000$40.27$161,080.0021,910View SEC Filing  
9/8/2015William M MooreDirectorSell3,006$40.09$120,510.5421,910View SEC Filing  
8/18/2015William M MooreDirectorSell3,000$45.62$136,860.0021,910View SEC Filing  
8/13/2015William M MooreDirectorSell4,000$45.55$182,200.00View SEC Filing  
7/24/2015Robert A GunstDirectorSell4,000$45.30$181,200.00View SEC Filing  
6/15/2015William M MooreDirectorSell6,000$41.30$247,800.00View SEC Filing  
6/8/2015James B HawkinsCEOSell100,000$42.08$4,208,000.00View SEC Filing  
6/3/2015Dong Chune Christopher ChungVPSell26,000$41.01$1,066,260.00View SEC Filing  
4/28/2015Kenneth M TraversoVPSell57,233$40.80$2,335,106.40View SEC Filing  
4/24/2015Doris EngibousDirectorSell15,000$42.20$633,000.00View SEC Filing  
2/3/2015Dong Chune Christopher ChungVPSell40,000$36.64$1,465,600.00View SEC Filing  
12/9/2014Jonathan KennedyCFOSell45,833$35.67$1,634,863.11View SEC Filing  
12/8/2014William M MooreDirectorSell4,451$34.65$154,227.15View SEC Filing  
12/5/2014William M MooreDirectorSell561$34.65$19,438.65View SEC Filing  
12/2/2014William M MooreDirectorSell2,278$3,478.00$7,922,884.00View SEC Filing  
11/4/2014James B HawkinsCEOSell18,400$34.10$627,440.00View SEC Filing  
10/30/2014Robert A GunstDirectorSell15,000$33.92$508,800.00View SEC Filing  
10/28/2014Dong Chune Christopher ChungVPSell50,000$33.14$1,657,000.00View SEC Filing  
10/28/2014James B HawkinsCEOSell251,600$33.31$8,380,796.00View SEC Filing  
10/27/2014Dong Chune Christopher ChungVPSell39,521$33.09$1,307,749.89View SEC Filing  
10/24/2014Kenneth M TraversoVPSell30,000$33.33$999,900.00View SEC Filing  
9/10/2014William M MooreDirectorSell2,200$29.30$64,460.00View SEC Filing  
9/8/2014William M MooreDirectorSell5,000$29.17$145,850.00View SEC Filing  
7/30/2014Austin Francis Noll IIIVPSell23,500$29.42$691,370.00View SEC Filing  
5/30/2014Ken LudlumDirectorSell2,500$24.77$61,925.00View SEC Filing  
2/24/2014James HawkinsCEOSell75,000$25.88$1,941,000.00468,844View SEC Filing  
2/13/2014James HawkinsCEOSell96,046$24.77$2,379,059.42468,844View SEC Filing  
2/4/2014James HawkinsCEOSell16,910$25.93$438,476.30468,844View SEC Filing  
12/4/2013James HawkinsCEOSell206,878$22.58$4,671,305.24413,844View SEC Filing  
10/29/2013Kenneth M TraversoVPSell25,000$19.54$488,500.00View SEC Filing  
9/12/2013Doris EngibousDirectorSell33,750$13.53$456,637.506,000View SEC Filing  
9/12/2013Kenneth M TraversoVPSell4,225$13.89$58,685.25View SEC Filing  
8/19/2013Dong Chune Christopher ChungVPSell5,818$12.78$74,354.04120,972View SEC Filing  
8/19/2013James HawkinsCEOSell22,190$12.78$283,588.20413,211View SEC Filing  
6/5/2013Kenneth M TraversoVPSell22,682$14.30$324,352.60View SEC Filing  
6/3/2013Kenneth M TraversoVPSell7,318$14.50$106,111.00View SEC Filing  
5/28/2013Steven J MurphyVPSell10,000$14.42$144,200.00View SEC Filing  
3/12/2013Robert A GunstDirectorBuy5,000$13.40$67,000.00View SEC Filing  
11/27/2012Robert A GunstDirectorBuy10,000$11.66$116,600.00View SEC Filing  
11/9/2012Kenneth M TraversoVPSell49,885$11.19$558,213.15View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Natus Medical (NASDAQ BABY) News Headlines

Source:
DateHeadline
Natus Medical Inc (BABY) Given Consensus Recommendation of "Hold" by BrokeragesNatus Medical Inc (BABY) Given Consensus Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - April 18 at 8:33 AM
Natus Medical (BABY) Set to Announce Quarterly Earnings on WednesdayNatus Medical (BABY) Set to Announce Quarterly Earnings on Wednesday
www.americanbankingnews.com - April 18 at 3:10 AM
Natus Medical Inc (BABY) Expected to Announce Quarterly Sales of $126.39 MillionNatus Medical Inc (BABY) Expected to Announce Quarterly Sales of $126.39 Million
www.americanbankingnews.com - April 18 at 2:28 AM
 Analysts Anticipate Natus Medical Inc (BABY) to Announce $0.24 Earnings Per Share Analysts Anticipate Natus Medical Inc (BABY) to Announce $0.24 Earnings Per Share
www.americanbankingnews.com - April 16 at 5:14 PM
Natus Medical (BABY) Downgraded by BidaskClubNatus Medical (BABY) Downgraded by BidaskClub
www.americanbankingnews.com - April 14 at 6:22 PM
Zacks Investment Research Upgrades Natus Medical (BABY) to HoldZacks Investment Research Upgrades Natus Medical (BABY) to Hold
www.americanbankingnews.com - April 10 at 8:30 AM
 Analysts Expect Natus Medical Inc (BABY) to Announce $0.24 EPS Analysts Expect Natus Medical Inc (BABY) to Announce $0.24 EPS
www.americanbankingnews.com - March 30 at 9:16 PM
Natus Medical (BABY) Downgraded by William BlairNatus Medical (BABY) Downgraded by William Blair
www.americanbankingnews.com - March 30 at 12:34 PM
Medical Electrodes Market to Grow Rapidly Owing to High Usage in Neonatal ECG, Neurophysiology and Electro ...Medical Electrodes Market to Grow Rapidly Owing to High Usage in Neonatal ECG, Neurophysiology and Electro ...
www.prnewswire.com - March 27 at 5:15 PM
Roth Capital Analysts Give Natus Medical (BABY) a $39.00 Price TargetRoth Capital Analysts Give Natus Medical (BABY) a $39.00 Price Target
www.americanbankingnews.com - March 24 at 8:55 PM
Intraoperative Neuromonitoring Market in the US 2018-2022 with Cadwell, SpecialtyCare, Computational Diagnostics ...Intraoperative Neuromonitoring Market in the US 2018-2022 with Cadwell, SpecialtyCare, Computational Diagnostics ...
www.prnewswire.com - March 24 at 5:16 PM
Natus Medical (BABY) Upgraded by BidaskClub to "Sell"Natus Medical (BABY) Upgraded by BidaskClub to "Sell"
www.americanbankingnews.com - March 24 at 1:10 PM
Natus Medical Inc (BABY) Receives Average Recommendation of "Hold" from AnalystsNatus Medical Inc (BABY) Receives Average Recommendation of "Hold" from Analysts
www.americanbankingnews.com - March 24 at 10:14 AM
Natus Medical (BABY) is in Overbought Territory: What's Next?Natus Medical (BABY) is in Overbought Territory: What's Next?
finance.yahoo.com - March 22 at 8:23 AM
Coffee-Shop Spat, Weak Guidance Lead to Board Fight at Natus MedicalCoffee-Shop Spat, Weak Guidance Lead to Board Fight at Natus Medical
www.wsj.com - March 20 at 5:19 PM
[$$] Spat, Weak Guidance Lead to Board Fight at Natus Medical[$$] Spat, Weak Guidance Lead to Board Fight at Natus Medical
finance.yahoo.com - March 20 at 5:19 PM
Natus Medical (BABY) Upgraded to Hold at BidaskClubNatus Medical (BABY) Upgraded to Hold at BidaskClub
www.americanbankingnews.com - March 17 at 2:50 PM
Zacks: Analysts Expect Natus Medical Inc (BABY) Will Announce Quarterly Sales of $126.23 MillionZacks: Analysts Expect Natus Medical Inc (BABY) Will Announce Quarterly Sales of $126.23 Million
www.americanbankingnews.com - March 15 at 3:47 AM
Insider Selling: Natus Medical Inc (BABY) Director Sells 4,000 Shares of StockInsider Selling: Natus Medical Inc (BABY) Director Sells 4,000 Shares of Stock
www.americanbankingnews.com - March 6 at 9:44 PM
Global newborn screening market expected to be driven by raising awareness about newborn screening testGlobal newborn screening market expected to be driven by raising awareness about newborn screening test
www.marketwatch.com - March 5 at 5:51 PM
See How Natus Medical Ranks Among Analysts Top Picks With Strong Buyback ActivitySee How Natus Medical Ranks Among Analysts' Top Picks With Strong Buyback Activity
www.nasdaq.com - March 1 at 5:53 PM
Natus Medical Inc (BABY) Files 10-K for the Fiscal Year Ended on December 31, 2017Natus Medical Inc (BABY) Files 10-K for the Fiscal Year Ended on December 31, 2017
finance.yahoo.com - March 1 at 5:53 PM
Natus Medical Inc (BABY) Stake Lowered by Systematic Financial Management LPNatus Medical Inc (BABY) Stake Lowered by Systematic Financial Management LP
www.americanbankingnews.com - February 27 at 4:23 PM
Natus Medical Inc (BABY) Receives Average Rating of "Hold" from AnalystsNatus Medical Inc (BABY) Receives Average Rating of "Hold" from Analysts
www.americanbankingnews.com - February 27 at 9:52 AM
Natus Medical (BABY) to Repurchase $30.00 million in  Outstanding SharesNatus Medical (BABY) to Repurchase $30.00 million in Outstanding Shares
www.americanbankingnews.com - February 22 at 11:12 AM
Natus Announces $30 Million Share Repurchase ProgramNatus Announces $30 Million Share Repurchase Program
finance.yahoo.com - February 22 at 8:18 AM
Natus Medical Inc to Post FY2018 Earnings of $1.63 Per Share, William Blair Forecasts (BABY)Natus Medical Inc to Post FY2018 Earnings of $1.63 Per Share, William Blair Forecasts (BABY)
www.americanbankingnews.com - February 12 at 6:54 AM
Natus Medical Hears a Rebound ComingNatus Medical Hears a Rebound Coming
finance.yahoo.com - February 10 at 9:37 AM
Free Post Earnings Research Report: Zimmer Biomet’s Quarterly Sales Grew 3%; Topped ExpectationsFree Post Earnings Research Report: Zimmer Biomet’s Quarterly Sales Grew 3%; Topped Expectations
finance.yahoo.com - February 9 at 9:40 AM
Why Natus Medical Incorporated Stock Lost 19% in JanuaryWhy Natus Medical Incorporated Stock Lost 19% in January
finance.yahoo.com - February 8 at 3:41 PM
Natus Medical Announces Fourth Quarter and Full Year 2017 Financial ResultsNatus Medical Announces Fourth Quarter and Full Year 2017 Financial Results
finance.yahoo.com - February 7 at 9:26 AM
Natus Medical Incorporated to Host Earnings CallNatus Medical Incorporated to Host Earnings Call
finance.yahoo.com - February 7 at 9:26 AM
Does Natus Medical Incorporated’s (NASDAQ:BABY) Past Performance Indicate A Weaker Future?Does Natus Medical Incorporated’s (NASDAQ:BABY) Past Performance Indicate A Weaker Future?
finance.yahoo.com - February 7 at 9:26 AM
Natus Medical reports 4Q lossNatus Medical reports 4Q loss
finance.yahoo.com - February 7 at 9:26 AM
Natus Medical (BABY) Issues Q1 Earnings GuidanceNatus Medical (BABY) Issues Q1 Earnings Guidance
www.americanbankingnews.com - February 7 at 9:10 AM
Natus Medical (BABY) Announces Quarterly  Earnings ResultsNatus Medical (BABY) Announces Quarterly Earnings Results
www.americanbankingnews.com - February 7 at 9:02 AM
Natus Medical (BABY) to Release Quarterly Earnings on WednesdayNatus Medical (BABY) to Release Quarterly Earnings on Wednesday
www.americanbankingnews.com - January 31 at 3:56 AM
Natus Medical Inc (BABY) Short Interest UpdateNatus Medical Inc (BABY) Short Interest Update
www.americanbankingnews.com - January 28 at 1:26 AM
Financial Comparison: Natus Medical (BABY) vs. Accuray (ARAY)Financial Comparison: Natus Medical (BABY) vs. Accuray (ARAY)
www.americanbankingnews.com - January 21 at 7:22 PM
Natus Medical Inc (BABY) Given Consensus Rating of "Hold" by AnalystsNatus Medical Inc (BABY) Given Consensus Rating of "Hold" by Analysts
www.americanbankingnews.com - January 20 at 12:02 AM
Detailed Research: Economic Perspectives on Basic Energy Services, Intercept Pharmaceuticals, Natus Medical, Surmodics, EnviroStarm, and Nicolet Bankshares — What Drives Growth in Todays Competitive LandscapeDetailed Research: Economic Perspectives on Basic Energy Services, Intercept Pharmaceuticals, Natus Medical, Surmodics, EnviroStarm, and Nicolet Bankshares — What Drives Growth in Today's Competitive Landscape
finance.yahoo.com - January 19 at 12:22 PM
Natus Medical to Hold 2017 Fourth Quarter Financial Results Conference Call on February 7thNatus Medical to Hold 2017 Fourth Quarter Financial Results Conference Call on February 7th
finance.yahoo.com - January 17 at 11:17 AM
Benchmark Lowers Natus Medical (BABY) Price Target to $49.00Benchmark Lowers Natus Medical (BABY) Price Target to $49.00
www.americanbankingnews.com - January 16 at 12:44 PM
Bear of the Day: Natus Medical (BABY)Bear of the Day: Natus Medical (BABY)
finance.yahoo.com - January 16 at 11:26 AM
Natus Medical (BABY) Downgraded by Zacks Investment ResearchNatus Medical (BABY) Downgraded by Zacks Investment Research
www.americanbankingnews.com - January 11 at 7:08 PM
Natus Medical Inc. (BABY) Is Losing Ground On Q1 ForecastNatus Medical Inc. (BABY) Is Losing Ground On Q1 Forecast
www.nasdaq.com - January 8 at 3:45 PM
Why Natus Medical Inc Sank Lower TodayWhy Natus Medical Inc Sank Lower Today
finance.yahoo.com - January 8 at 3:45 PM
Form 8-K NATUS MEDICAL INC For: Jan 08 - StreetInsider.comForm 8-K NATUS MEDICAL INC For: Jan 08 - StreetInsider.com
www.streetinsider.com - January 8 at 8:36 AM
Natus Medical Announces 2018 Annual and First Quarter Financial GuidanceNatus Medical Announces 2018 Annual and First Quarter Financial Guidance
finance.yahoo.com - January 8 at 8:36 AM
$145.85 Million in Sales Expected for Natus Medical Inc (BABY) This Quarter$145.85 Million in Sales Expected for Natus Medical Inc (BABY) This Quarter
www.americanbankingnews.com - January 7 at 6:26 PM

SEC Filings

Natus Medical (NASDAQ:BABY) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Natus Medical (NASDAQ:BABY) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Natus Medical (NASDAQ BABY) Stock Chart for Thursday, April, 19, 2018

Loading chart…

This page was last updated on 4/19/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.